Luckwel Pharmaceuticals Inc.: key financial figures for fiscal year 2020 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Net Income/Loss (FY2020)
- -$436.0K
- Total Assets (FY2020)
- $46.7K
- Total Equity (FY2020)
- -$444.3K
- Cash Flows from Operating Activities (FY2020)
- -$198.0K
Source: Luckwel Pharmaceuticals Inc. 10-K filing (FY2020). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
